PAVmed (NASDAQ:PAVM) Price Target Raised to $19.50
PAVmed (NASDAQ:PAVM – Free Report) had its price objective upped by Ascendiant Capital Markets from $19.00 to $19.50 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the stock. PAVmed Price Performance PAVmed stock opened at $0.66 on Monday. PAVmed has a one year low of $0.55 and a […]
PAVmed (NASDAQ:PAVM – Free Report) had its price objective upped by Ascendiant Capital Markets from $19.00 to $19.50 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the stock. PAVmed Price Performance PAVmed stock opened at $0.66 on Monday. PAVmed has a one year low of $0.55 and a […]